Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Anticipation and Child Development

International audienc

Anticipation and Child Development

International audienc

Anticipation and Child Development

International audienc

Oculométrie et anticipation : apport dans la compréhension du développement cognitif typique et atypique

International audienc

Les figures de la prématurité

International audienc

4. Troubles de la relation et liens entre enfants

International audienc

Etude longitudinale des interactions prosodiques précoces entre parent et enfant ultérieurement diagnostiqué autiste

International audienceThe goal of this retrospective and longitudinal study is to compare the early development of prosodic interactions between the parent and typically developing child (n = 13) and between the parent and child later diagnosed with autism (n = 11). This study is based on an acoustic analysis of family home movies filmed during the child’s first year of life. Durations of engagement and disengagement phases as well as response latencies have been measured. The results show comparable trajectories before the age of seven months, whereas differences appear between groups after the age of eight months. Thus, a better understanding of the development of autism spectrum disorder will encourage early screening and therefore starting treatment earlier.Cette étude rétrospective et longitudinale cherche à comparer le développement précoce des interactions prosodiques entre parent et enfant typique (n = 13) et entre parent et enfant ultérieurement diagnostiqué autiste (n = 11). Elle se base sur l’analyse acoustique de films familiaux réalisés lors de la première année de vie de l’enfant. Les durées d’engagement et de désengagement, ainsi que les latences de réponse vocale ont été mesurées. Les résultats montrent que les trajectoires des deux groupes sont identiques jusqu’à 7 mois et se distinguent à partir de 8 mois. Ainsi, comprendre le développement des troubles du spectre autistique aidera au repérage des premiers signes

L’expérience de la fatigue chronique de patients atteints de SFC/EM, d’une MICI et de sujets tout-venant : étude quantitative et qualitative du discours préalable à la création d’une échelle d’évaluation de l’asthénie chronique

International audienc

Psychometric validation of the French Multidimensional Chronic Asthenia Scale (MCAS) in a sample of 621 patients with chronic fatigue

Abstract Background Psychometric validation of the Multidimensional Chronic Asthenia Scale (MCAS) was conducted in order to provide an effective tool for assessing the health-related quality of life of French-speaking patients with chronic asthenia (CA). Methods Items resulting from the initial formulation of the self-reported MCAS (along with other materials) were completed by French-speaking volunteers with inactive or active inflammatory bowel disease (IBD-I vs. IBD-A) or chronic fatigue syndrome (CFS). Responses from 621 participants (180 patients with IBD-A, 172 with IBD-I, 269 with CFS) collected in a single online survey were divided into three subsamples to test the construct validity of the MCAS (Step 1, N = 240), to confirm its factorial structure (Step 2, N = 204) and to explore its convergent-discriminant validity with the Fatigue Symptoms Inventory (FSI) and revised Piper Fatigue Scale (r-PFS, Step 3, N = 177). Results Steps 1 and 2 showed that, as expected, MCAS has four dimensions: feeling of constraint (FoC), physical (PC), life (LC) and interpersonal consequences (IC), which are also related to the duration of CA (i.e., the longer it lasts, the more the dimensions are impacted). The results further showed that the MCAS is sensitive enough to capture between-group differences, with the CFS group being the most impaired, followed by IBD-A and IBD-I. While convergent-discriminant validity between the 4 factors of MCAS and FSI and r-PFS, respectively, was satisfactory overall, Step 3 also pointed to some limitations that call for future research (e.g., shared variances between the PC and IC dimensions of MCAS and behavioral dimension of r-PFS). Conclusion Despite these limitations, the MCAS clearly constitutes a promising tool for measuring quantitative differences (i.e., severity/intensity) in CA associated with various diseases, but also, and importantly, the clinically important differences in domains of its expression (i.e., qualitative differences)